Compare Mutual Funds
Risk
Very High
-
Rating
5.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.11
-
NAV
₹45.09
-
Fund Started
25 Jun 2018
-
Fund Size
₹6453.52 Cr
-
Exit Load
Exit load of 1% if redeemed within 15 days.
-
1 Year
5.40%
-
3 Year
26.73%
-
5 Year
15.16%
-
Equity
99.82%
-
Cash
0.18%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.09% |
Dr. Reddy's Laboratories Ltd. | 7.70% |
Cipla Ltd. | 7.45% |
Mankind Pharma Ltd. | 7.03% |
Divi's Laboratories Ltd. | 6.06% |
Biocon Ltd. | 4.71% |
Cohance Lifesciences Ltd. | 4.37% |
Alkem Laboratories Ltd. | 4.08% |
Medplus Health Services Ltd. | 3.86% |
Max Healthcare Institute Ltd. | 3.36% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
-
Launch Date
25 Jun 2018
-
